ArticleScientific reports2025
Intraoperative albumin use and postoperative acute kidney injury in patients undergoing noncardiac surgery.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Albumin in Cardiac Surgery-Associated Acute Kidney Injury: Therapeutic Target or Epiphenomenon?Annals of cardiac anaesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The beneficial effects of albumin use have been suggested in various clinical settings including critically ill patients. However, the association between intraoperative albumin administration and acute kidney injury (AKI) after noncardiac surgery is unclear. This is a retrospective, hospital registry-based study including 39,336 adult patients who underwent intermediate to high risk noncardiac surgery between January 2011 and June 2019 at single tertiary hospital. The patients were divided into two groups based on exposure to 5% albumin during intraoperative period. The primary outcome was the incidence of AKI within seven days after surgery. Among 39,336 patients, 1725 (4.4%) patients were administered 5% albumin during the intraoperative period. The incidence of AKI was 3.4% (1285/37,611) in the albumin non-exposure group and 13.0% (225/1725) in the albumin exposure group. After 1:3 propensity score matching, 5221 patients (albumin non-exposures 3697; albumin exposures 1524) were included in the analysis. After propensity score matching and adjustment for residual confounders, albumin exposure was associated with higher risk of postoperative AKI (odds ratio = 1.82; 95% confidence interval, 1.41-2.34; p < 0.001). This association persisted in sensitivity analyses, including a subgroup with estimated blood loss < 500 mL (odds ratio = 2.40; 95% confidence interval, 1.76-3.28; p < 0.001), and in the entire cohort (odd ratio = 2.44; 95% confidence interval, 1.97-3.02; p < 0.001). Intraoperative 5% albumin use during noncardiac surgery was associated with increased risk of postoperative AKI. Our results should be verified in further studies to guide the optimal choice of fluid in noncardiac surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.